Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2019Trends in Cardiovascular MedicineOpen Access

The subcutaneous implantable cardioverter defibrillator in 2019 and beyond

View Full Paper
Ask AI
Bookmark
Share

Key result

S-ICD evolves into an effective alternative to transvenous ICDs driven by technical improvements.

Why the study?

Does the subcutaneous implantable cardioverter defibrillator provide a safe and effective alternative to transvenous ICDs for ventricular arrhythmia?

Comparison

S-ICD vs TV-ICD

Design

Review

Authors

VDVincent F. van DijkLBLucas V.A. Boersma

Discussion

Loading...

Member takes

Overview

Advances support S-ICD consideration in select patients; leaves open confirmatory RCTs before broad adoption.

Structured PICO

Does the subcutaneous implantable cardioverter defibrillator provide a safe and effective alternative to transvenous ICDs for ventricular arrhythmia?

P
Population
Patients requiring implantable cardioverter defibrillators for ventricular arrhythmia
I
Intervention
Subcutaneous implantable cardioverter defibrillator (S-ICD)
C
Comparator
Transvenous implantable cardioverter defibrillator (TV-ICD)

The S-ICD is evolving into a complete alternative to transvenous ICDs, with ongoing technical improvements addressing initial limitations such as pacing capabilities and inappropriate shocks.

Limitations

  • More data are warranted regarding reduced inappropriate shock rates

Cite This Study

Dijk et al. (2019) conducted a review in Ventricular arrhythmia. Subcutaneous implantable cardioverter defibrillator (S-ICD) vs. Transvenous ICD (TV-ICD) was evaluated. The subcutaneous implantable cardioverter defibrillator is evolving through technical improvements to become an effective alternative to transvenous ICDs for ventricular arrhythmias.

synapsesocial.com/papers/6a0eb4bf06ecbe833447b80fhttps://doi.org/10.1016/j.tcm.2019.09.006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Six‐year follow‐up of the initial Dutch subcutaneous implantable cardioverter‐defibrillator cohort: Long‐term complications, replacements, and battery longevity2018 · 47 citations
  2. 2Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results2019 · 65 citations
  3. 3A New Algorithm to Reduce Inappropriate Therapy in the S‐ICD System2015 · 122 citations
  4. 4Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator2018 · 172 citations
  5. 52015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing2015 · 246 citations